Artificial intelligence (AI) is playing an increasingly important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images.

Global Artificial Intelligence in Oncology Market Key Takeaways

According to Coherent Market Insights (CMI), the global artificial intelligence in oncology market size is expected to grow more than 7.6X, from USD 2,145.1 Mn in 2025 to USD 16,382 Mn by 2032, exhibiting a robust CAGR of 33.7%.

Based on component, software/platform segment is anticipated to account for a prominent market share of 64.2% in 2025.

North America is expected to retain its dominance, accounting for more than one-third of the global artificial intelligence in oncology market share in 2025.

Europe is projected to remain the second-leading market for AI-powered oncology companies.

As per Coherent Market Insights’ new global artificial intelligence in oncology market analysis, Asia Pacific is poised to witness fastest growth throughout the assessment period.

Increasing Cancer Prevalence Spurring Market Growth

Coherent Market Insights’ latest global artificial intelligence in oncology market research report highlights key factors driving market growth. One such prominent growth factor is the rising incidence of cancer.

The IARC’s Global Cancer Observatory projects that annual new cancer cases will surpass 35 million by 2050. This sharp rise in cancer incidence is anticipated to drive demand for artificial intelligence in oncology.

Artificial intelligence is revolutionizing oncology by enhancing cancer detection, treatment planning, and drug discovery. Therefore, growing cancer burden is poised to play a crucial role in driving adoption of AI-based oncology solutions over the forecast period.

High Implementation Costs and Data Privacy Concerns Restraining Market Growth

The global artificial intelligence in oncology market outlook indicates strong future growth. However, high implementation costs and data security concerns are limiting market growth to some extent.

Integrating AI technologies into oncology workflows requires significant investment in hardware and software. This deters small and mid-sized healthcare companies from opting for these technologies, thereby reducing global artificial intelligence in oncology market demand.

AI systems require access to large amounts of patient data, raising concerns about cybersecurity risks as well as potential misuse. This may also negatively impact the global artificial intelligence in oncology market growth during the projection period.

Get Instant Access! Purchase Research Report and Receive a 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/6509

Technological Advancements in AI Creating New Growth Prospects for the Market

Ongoing innovations in deep learning, computer vision, and natural language processing (NLP) are significantly enhancing AI applications in image analysis, drug discovery, and prognosis prediction. Such breakthroughs are expected to unlock new revenue-generation streams for industry players.

Advanced AI technologies are being increasingly integrated with imaging modalities like MRI and PET scans. This integration enables automated detection of anomalies, enhances diagnostic accuracy, and reduces human error.

Emerging Global Artificial Intelligence in Oncology Market Trends

Rising demand for precision medicine is a key growth-shaping trend in the market. Precision oncology requires analyzing large datasets, including genomics and biomarkers. This is where AI steps in, processing huge data and enabling creation of individualized therapies.

Expanding use of artificial intelligence in radiology and pathology is expected to boost the market. AI technologies are being increasingly used for tumor detection, segmentation, and classification through radiological and histopathological images. This is due to their ability to improve speed and consistency as well as reduce diagnostic errors.

Increasing adoption of AI in drug discovery and development is positively impacting the global artificial intelligence in oncology market value. This advanced technology is revolutionizing drug discovery by rapidly analyzing large datasets to identify potential drug candidates as well as predict their efficacy and toxicity.

Growing adoption of cloud-based AI solutions is significantly contributing to the expansion of the global artificial intelligence in oncology market. These solutions are increasingly favored for their cost-efficiency, scalability, and ability to provide seamless remote access to data and tools.

Analyst’s View

“The global artificial intelligence in oncology market is set for rapid expansion, owing to growing prevalence of cancer, rising adoption of precision medicine, and technological advancements in AI technologies,” said senior analyst Komal Dighe.

Current Events and Their Impact on the Global Artificial Intelligence in Oncology Market

Event

Description and Impact

FDA Clears First GenAI-Powered Diagnostic Tool for Breast Cancer Detection (2025)

  • Description: The U.S. FDA approved a GenAI-based diagnostic platform by PathIntel, capable of identifying breast cancer subtypes with high accuracy using real-world data.
  • Impact: Such approvals signal growing regulatory acceptance of generative AI in oncology.

Tempus Collaborated with Boehringer to Accelerate AI Usage in Oncology

  • Description: In May 2025, Tempus entered a multi-year strategic collaboration with Boehringer Ingelheim to apply its AI-driven oncology insights toward cancer-focused therapeutic discovery and biomarker development
  • Impact: This will likely boost growth of the AI in oncology market.

Japan’s MHLW Updates Reimbursement Guidelines for AI Diagnostics

  • Description: Japanese Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for certain AI-enhanced imaging diagnostics
  • Impact: Such initiatives will increase commercial viability and adoption of AI oncology tools in Asia-Pacific, spurring more localized R&D and product launches.

Competitor Insights

Key companies listed in the global artificial intelligence in oncology market report:

- IBM Corporation

- Intel Corporation

- Azra AI

- NVIDIA Corporation

- Siemens Healthineers AG

- GE HealthCare

- Digital Diagnostics Inc.

- ConcertAI

- PathAI

- Median Technologies

- Microsoft

- Babylon

- Zebra Medical Vision

Key Developments

In June 2025, Viz.ai launched a new strategic alliance with Novartis to accelerate timely diagnosis and deliver AI-powered precision care for cancer patients. Through this collaboration, Viz.ai will focus on developing AI-powered workflows for breast and prostate cancer.

In November 2024, PathAI unveiled PathExplore Fibrosis. This new AI-powered tool is designed to revolutionize collagen, fibrosis, and fiber quantification directly from whole-slide images.

In January 2024, PathAI launched six additional oncology indications for PathExplore, expanding the AI-driven pathology panel to cover ovarian, bladder, liver, small cell lung, lymphoma, and head & neck cancers.

Global Artificial Intelligence in Oncology Market Segmentation:

By Component

Software/Platform

Hardware

Services

By Cancer Type

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Brain Tumor

Others

By Treatment Type

Chemotherapy

Radiotherapy

Immunotherapy

Others

By End User:

Hospitals & Clinics

Diagnostic Centers

Biopharmaceutical Companies

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Shah
Email: Send Email
Phone: + 12524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Country: United States
Website: https://www.coherentmarketinsights.com/industry-reports/global-artificial-intelligence-in-oncology-market

 

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]